Rite Aid Corp. (RAD)

18.10
0.88 5.10
NYSE : Retail Trade
Prev Close 17.22
Open 17.50
Day Low/High 17.31 / 18.62
52 Wk Low/High 5.04 / 23.88
Volume 5.33M
Avg Volume 4.69M
Exchange NYSE
Shares Outstanding 54.70M
Market Cap 941.99M
EPS -8.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

What Rite Aid Has to Do With Greece

Take advantage of irrational collateral damage to stocks.

Failed Greece Negotiations Hit Futures; Dollar Worries Persist

Failed Greece Negotiations Hit Futures; Dollar Worries Persist

But investors are likely to be wary ahead of the Fed meeting.

Fitbit IPO, FOMC Meeting: What to Watch in the Week Ahead

Fitbit IPO, FOMC Meeting: What to Watch in the Week Ahead

For the week of June 15, we outline the Fitbit IPO, notable quarterly earnings reports, as well as key economic data to watch on Wall Street.

Dish Jumps on Deal Reports; Crude Sells Off Ahead of OPEC Meeting

Dish Jumps on Deal Reports; Crude Sells Off Ahead of OPEC Meeting

Dish Network (DISH) spiked on reports the company is discussing a potential merger with T-Mobile (TMUS).

It's Getting Harder to Find Top-Ranked Stocks Under $10

But if you can stand the volatility, they're out there.

Health Care Mergers Are Just Getting Started

Deals coming fast and furious in the best group in town.

Bull Chart of the Day: RAD

Bull Chart of the Day: RAD

Rite Aid has been strong during the past month.

Market Wrap: Late Fade Sinks Stocks

Market Wrap: Late Fade Sinks Stocks

Major averages give up gains, but oil climbs.

Enough Already About the Fed

There are much more important things going on.

The 7 Pillars of Healthcare Strength

The 7 Pillars of Healthcare Strength

Here are healthcare stocks of all shares and sizes with strong charts.

Rite Aid Looks Like the Right Move

Rite Aid Looks Like the Right Move

Feeling aggressive toward a single-digit stock.

Cramer: Stay With the Winning Horse

When they aren't winning, they're hard to turn around.

My Portfolio Report Card

My Portfolio Report Card

This portfolio is up 2.9% for the month,

Turn the Page

Turn the Page

A new portfolio for the new year.

A Combination to Knock out the Markets

Combining value, momentum, and safe holdings.

Rite Aid numbers boosted at JP Morgan

Cramer: Six Quick Rays of Light

We shouldn't expect lasting blows coming from oil's decline.

The Fibocall: Rite Aid

The Fibocall: Rite Aid

Watch today's close for the right time to buy.

Cramer: Apple Is a Win for Walgreen

Cramer: Apple Is a Win for Walgreen

Adopting Apple's payment system is a smart move.

Jim Cramer: Rite Aid and CVS Won't Play Ball With Apple Pay

Jim Cramer: Rite Aid and CVS Won't Play Ball With Apple Pay

TheStreet's Jim Cramer shares his thoughts on drug retailers Rite Aid and CVS refusing to accept Apple Pay at their stores.

Five Things to Know Now: Stress Tests and Apple

Stress test results in Europe did not reveal major shortfalls.

Moving Into the Danger Zone, Part I

Moving Into the Danger Zone, Part I

It's time to check the trends in earnings estimates.

Cramer: Walgreen Is Going Higher Long Term, Now Is an Opportunity

Cramer: Walgreen Is Going Higher Long Term, Now Is an Opportunity

With Walgreen's earnings report coming up next week, Jim Cramer says this is a stock that's been beaten up but has long-term potential.

The Fibocall: Rite Aid

The Fibocall: Rite Aid

Let's see what the technical view has to say about this sickly stock.

Rite Aid numbers cut at JP Morgan

Can Sears and Rite Aid Come Back?

I believe only one is worth owning.

Think Globally, Buy Locally

Companies with international exposure may be in for a world of hurt.

The Tell of When to Sell

The Tell of When to Sell

If you're worried about these moves, it's time to cash out.

Risk and Stability

Risk and Stability

Staples may be read to move up, while Apple could hit triple digits.

Cramer: When Monsanto Gets Hit on Earnings, It Will Be Time to Buy

Cramer: When Monsanto Gets Hit on Earnings, It Will Be Time to Buy

Jim Cramer weighs in on two key earnings reports this week from Walgreen and Monsanto.